Pitavastatin
- Generic Name
- Pitavastatin
- Brand Names
- Livalo, Zypitamag
- Drug Type
- Small Molecule
- Chemical Formula
- C25H24FNO4
- CAS Number
- 147511-69-1
- Unique Ingredient Identifier
- M5681Q5F9P
- Background
Pitavastatin, also known as the brand name product Livalo, is a lipid-lowering drug belonging to the statin class of medications. By inhibiting the endogenous production of cholesterol within the liver, statins lower abnormal cholesterol and lipid levels and ultimately reduce the risk of cardiovascular disease. More specifically, statin medications competiti...
- Indication
用于治疗高胆固醇症(高脂血症)、家族性高胆固醇症。
- Associated Conditions
- Apolipoprotein B increased, Elevation of serum triglyceride levels, Increases in serum total low-density lipoprotein (LDL), Increases in total cholesterol
- Associated Therapies
- -
Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients
- Conditions
- Interventions
- First Posted Date
- 2005-11-23
- Last Posted Date
- 2010-03-16
- Lead Sponsor
- Kowa Research Europe
- Target Recruit Count
- 962
- Registration Number
- NCT00257686
- Locations
- 🇳🇱
Vasculair Onderzoek Centrum Hoorn, Hoorn, Netherlands
🇩🇰CCBR A/S, Vejle, Denmark
🇩🇰Copenhagen University Hospital, Copenhagen, Denmark
Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels
- Conditions
- First Posted Date
- 2005-11-07
- Last Posted Date
- 2010-01-12
- Lead Sponsor
- Kowa Research Europe
- Target Recruit Count
- 830
- Registration Number
- NCT00249249
- Locations
- 🇳🇴
Rikshospitalet - University Hospital, Oslo, Norway
🇳🇴Skedsmo Medisinske Senter A.S., Skedsmokorset, Norway
🇮🇳Sir J. J. Group of Hospitals, Maharashtra, India
Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)
- Conditions
- Interventions
- First Posted Date
- 2005-10-21
- Last Posted Date
- 2023-10-04
- Lead Sponsor
- Kyoto University
- Target Recruit Count
- 307
- Registration Number
- NCT00242944
- Locations
- 🇯🇵
Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan
🇯🇵Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan
🇯🇵Kyoto University Graduate School of Medicine, Kyoto, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.